Guard Therapeutics International AB (publ) (STO:GUARD)

Market Cap	473.94M
Revenue (ttm)	n/a
Net Income (ttm)	-115.77M
Shares Out	20.17M
EPS (ttm)	-9.89
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,309
Average Volume	31,186
Open	23.40
Previous Close	23.50
Day's Range	22.80 - 23.40
52-Week Range	11.85 - 33.37
Beta	-0.21
RSI	70.11
Earnings Date	Aug 19, 2025

About STO:GUARD

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is ba...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 12
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: GUARD